Edition:
India

People: Zogenix Inc (ZGNX.OQ)

ZGNX.OQ on NASDAQ Stock Exchange Global Market

37.81USD
9:21pm IST
Change (% chg)

$0.59 (+1.59%)
Prev Close
$37.22
Open
$37.46
Day's High
$37.97
Day's Low
$37.27
Volume
27,519
Avg. Vol
214,695
52-wk High
$62.75
52-wk Low
$33.56

Smith, Michael 

Mr. Michael P. Smith is the Chief Financial Officer, Executive Vice President, Treasurer, Secretary of Zogenix Inc, effective January 16, 2017. Mr. Smith previously served as Chief Financial Officer for Raptor Pharmaceutical Corp. from January 2015 to December 2016. Mr. Smith previously recently served as Chief Financial and Business Advisor at Catalyst Biosciences, a privately held biopharmaceutical company, from May 2012 to January 2015. From September 2010 to April 2011, he was Vice President of Business Development at iPierian, Inc., a privately held biotechnology company, and from June 2006 to July 2009, he served as Head of Business Development and Chief Financial Officer of Memory Pharmaceuticals Corporation, a publicly held biopharmaceutical company. Mr. Smith received a B.S. from the University of Virginia and an M.B.A. from the Haas School of Business at the University of California, Berkeley.

Basic Compensation

Total Annual Compensation, USD 558,634
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 945,983
Fiscal Year Total, USD 1,504,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Cam Garner

259,644

Stephen Farr

1,980,630

Michael Smith

1,504,620

Gail Farfel

917,177

Bradley Galer

1,007,910

Ashish Sagrolikar

--
As Of  31 Dec 2017